Pyxis Oncology, Inc. was dropped from several Russell indices, including the Russell 3000 Index, Russell 2000 Index, Russell 2500 Index, and their respective value and dynamic counterparts. This change occurred as part of the annual reconstitution of the Russell indices.
Inclusion in these indices is often a factor for institutional investors, particularly those managing index funds or funds benchmarked against these indices. Being removed can lead to reduced institutional ownership and potentially lower trading liquidity.
The company's removal from these broad market and small-cap indices reflects its current market capitalization and other eligibility criteria used during the reconstitution process. This event may impact the company's visibility among certain investor segments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.